IBO Annual Total Long Term Liabilities
$3.23 M
$0.000.00%
01 December 2023
Summary:
As of February 3, 2025, IBO annual total long term liabilities is $3.23 million, unchanged on December 1, 2023. During the last 3 years, it has fallen by -$2.02 million (-38.40%). IBO annual total long term liabilities is now -38.40% below its all-time high of $5.25 million, reached on December 1, 2020.IBO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBO Quarterly Long Term Liabilities
$11.21 M
+$7.97 M+246.40%
01 September 2024
Summary:
As of February 3, 2025, IBO quarterly total long term liabilities is $11.21 million, with the most recent change of +$7.97 million (+246.40%) on September 1, 2024. Over the past year, it has increased by +$7.97 million (+246.40%). IBO quarterly long term liabilities is now at all-time high.IBO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | +246.4% |
| 3 y3 years | -38.4% | - |
| 5 y5 years | +100.0% | - |
IBO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.1% | at low | at high | +246.4% |
| 5 y | 5-year | -38.4% | at high | ||
| alltime | all time | -38.4% | at high |
Impact BioMedical Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.21 M(+246.4%) |
| June 2024 | - | $3.23 M(0.0%) |
| Mar 2024 | - | $3.23 M(0.0%) |
| Dec 2023 | $3.23 M(0.0%) | $3.23 M(0.0%) |
| Sept 2023 | - | $3.23 M(0.0%) |
| June 2023 | - | $3.23 M(0.0%) |
| Mar 2023 | - | $3.23 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.23 M(-16.1%) | $3.23 M(-36.7%) |
| Sept 2022 | - | $5.11 M(+32.6%) |
| Mar 2022 | - | $3.86 M(0.0%) |
| Dec 2021 | $3.86 M(-26.6%) | $3.86 M(-23.2%) |
| June 2021 | - | $5.02 M(-4.3%) |
| Dec 2020 | $5.25 M(>+9900.0%) | $5.25 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is Impact BioMedical annual total long term liabilities?
- What is the all time high annual total long term liabilities for Impact BioMedical?
- What is Impact BioMedical annual total long term liabilities year-on-year change?
- What is Impact BioMedical quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Impact BioMedical?
- What is Impact BioMedical quarterly long term liabilities year-on-year change?
What is Impact BioMedical annual total long term liabilities?
The current annual total long term liabilities of IBO is $3.23 M
What is the all time high annual total long term liabilities for Impact BioMedical?
Impact BioMedical all-time high annual total long term liabilities is $5.25 M
What is Impact BioMedical annual total long term liabilities year-on-year change?
Over the past year, IBO annual total long term liabilities has changed by $0.00 (0.00%)
What is Impact BioMedical quarterly total long term liabilities?
The current quarterly long term liabilities of IBO is $11.21 M
What is the all time high quarterly long term liabilities for Impact BioMedical?
Impact BioMedical all-time high quarterly total long term liabilities is $11.21 M
What is Impact BioMedical quarterly long term liabilities year-on-year change?
Over the past year, IBO quarterly total long term liabilities has changed by +$7.97 M (+246.40%)